4//SEC Filing
Linde Peter 4
Accession 0001209191-20-020055
CIK 0001679363other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 5:30 PM ET
Size
10.5 KB
Accession
0001209191-20-020055
Insider Transaction Report
Form 4
Linde Peter
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit (RSU)
2020-03-16+45,460→ 45,460 totalExp: 2024-03-16→ Common Stock (45,460 underlying) - Award
Stock Option (right to buy Common Stock)
2020-03-16+181,840→ 181,840 totalExercise: $10.84Exp: 2030-03-15→ Common Stock (181,840 underlying) - Award
Restricted Stock Unit (RSU)
2020-03-16+20,756→ 20,756 totalExp: 2021-09-16→ Common Stock (20,756 underlying)
Footnotes (4)
- [F1]The option vests as to 1/4 of the total shares on March 16, 2021, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on March 16, 2024, subject to the reporting person's provision of service to the Issuer on each vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F3]The RSU vests 25% on each of March 16, 2021, March 16, 2022, March 16, 2023 and March 16, 2024, subject to the reporting person's provision of service to the Issuer on each vesting date.
- [F4]The RSU vests 50% on March 16, 2021 and the remaining 50% vests on September 16, 2021, subject to the reporting person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Morphic Holding, Inc.
CIK 0001679363
Entity typeother
Related Parties
1- filerCIK 0001805908
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 5:30 PM ET
- Size
- 10.5 KB